OCI stock closed at €4.08 after a muted few weeks, barely moving over the past month even as fresh earnings confirmed the business remains loss making. The near term share drift hides the bigger story. This fertilizer producer now trades on a P/S of 0.9x, while the wider European chemicals group sits nearer 1.1x.
The real headline is the profit squeeze. Trailing twelve month figures show a continued loss from ongoing operations and a reported cash runway of under a year. That mix of thin valuation, persistent red ink and liquidity pressure is what now drives the long term debate on OCI.
Is OCI a deep-value outlier at a 0.9x P/S with reported losses and a cash runway under a year, or is the discount fully deserved? Compare that gap against our valuation analysis for OCI
Prefer clean charts instead of scrolling through blocks of earnings tables and raw loss figures for OCI? See the full visual breakdown of OCI, including how its valuation compares with its recent performance, in the interactive company report for OCI.
Bulls argue OCI is less a fertilizer producer and more an asset realisation story, where monetisations and pro forma equity matter more than near term nitrogen earnings. Recent numbers only partially support that. Net income from discontinued operations of US$527.5 million over the trailing period shows sizeable value already crystallised away from the loss making core. That backs the view that reported operating losses do not tell the full equity story. At the same time, continuing operations still report a loss of US$343.7 million and basic EPS remains in the red at US$1.63 per share. The SunRoper solar project and shift toward owning renewable assets signal an effort to build a new earnings base, but this is a long dated effort. The bullish pitch that asset sales and new platforms offset the weak nitrogen franchise is only partly validated so far.
Sceptics say OCI is a structurally weak European nitrogen business with persistent losses, a short cash runway and a complex corporate endgame that may never fully pay off. The latest trailing figures lend weight to that concern. Losses from continuing operations widened slightly compared with the prior period and EPS remains loss making, which supports the idea that the underlying franchise still consumes capital. Reported cash runway of under a year keeps liquidity front of mind for a cyclical operator exposed to gas prices. Legal challenges to the Orascom merger underline execution and timing risk around corporate actions that are supposed to crystallise value, even if some shareholder opposition has softened. The share price has been broadly flat over 30 and 90 days, which fits a market that is yet to reward the promised simplification while the loss profile persists.
After a 28.6% annual earnings decline over five years and less than one year of cash runway, you may want to review the full risk analysis for OCI which shows 3 important warning signsOCI now trades on a compressed P/S multiple with ongoing losses and a short reported cash runway, which makes timing and risk management especially important for anyone watching the stock. Register free with Simply Wall St and add OCI to your Watchlist to track its share price against fair value estimates and keep an eye on fresh financial data before deciding on an entry point. Once you own any positions, use the Portfolio Command Center to cut through noise and focus on the key alerts that matter for your holdings. For a longer term plan, tap into the Community to see how other investors are thinking about catalysts, restructuring plans and risk factors so you can spot potential triggers or warning signs early and stay ahead of the market.
Fresh ideas move first. While attention lingers on laggards, new themes can build quiet momentum under the radar for now. Scan upcoming stories before they get fully priced and act now.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com